Today it was reported that a Director at Achillion Pharmaceuticals (ACHN), Robert Van-Nostrand, exercised options to buy 20,000 ACHN shares at $1.05 a share, for a total transaction value of $21K. The options were close to expired and Robert Van-Nostrand retained stocks.
Following this transaction Robert Van-Nostrand’s holding in the company was increased by 100% to a total of $48K.
See today’s analyst top recommended stocks >>
Currently, Achillion Pharmaceuticals has an average volume of 9.15M.
Robert Van-Nostrand’s trades have generated a -18.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.
